Transgene SA, a developer of virus-based immunotherapies for cancer, has appointed Lucie Larguier as chief financial officer to lead the company’s financial strategy and ensure the efficient delivery of its immunotherapy pipeline. Previously Ms Larguier was Transgene’s vice president, corporate communication, and investor relations and contributed to the execution of four securities transactions. She holds a masters’ degree in communications and a minor in finance from the Paris Institute of Political Studies (Sciences Po), France. Separately, Transgene promoted Christelle Schwoerer to chief human resources officer. She joined Transgene’s human resources department in 2013.
Transgene announced the appointments on 27 March 2024.
Copyright 2024 Evernow Publishing Ltd